Open-House Biologics Discount Contracts 2026-07 - Tocilizumab

Auto-translated from Englisch

Original title: Open-House-Biologika-Rabattverträge 2026-07 - Tocilizumab

Techniker Krankenkasse

Published: Mar 19, 2026

Updated: May 9, 2026

Source: TED - Tenders Electronic Daily (EU)

Summary

Translated

This tender concerns the establishment of discount contracts for the pharmaceutical product Tocilizumab, a biologic medication, under an 'Open-House' procedure for the contract period starting July 2026. The legal basis for these contracts is § 130a Abs. 8 SGB V (German Social Code Book V), which governs agreements between statutory health insurance funds and pharmaceutical manufacturers or wholesalers. The 'Open-House' model allows multiple manufacturers or suppliers to participate and negotiate discounts, fostering competition. Tocilizumab is typically used to treat inflammatory conditions such as rheumatoid arthritis, systemic juvenile idiopathic arthritis, and cytokine release syndrome. The tender aims to secure cost-effective supplies of this important medication for the statutory health insurance system, ensuring patient access while managing healthcare expenditures. The specific terms, discount levels, and supply obligations will be detailed in the negotiated contracts.

Description

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Tocilizumab im Rahmen eines Open-House-Verfahrens.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals and Health Financing. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before April 30, 2028.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.